Manufacture all your products with maximum flexibility at affordable costs

No more products in quarantine, no more rejects, no more scale-up: COST REDUCTION
Continuous processing leads the way to a risk based approach and lean manufacturing. Process know-how and control on a micro-scale results in guaranteed quality, avoiding end of line testing and allowing for parametric product release. Full flexibility in batch size (simply by adjusting the time of production) enables you to produce your products to meet demand, producing exactly the quantity you need, while reducing your expensive clean room space to a minimum.

Drastically reduces time to market of new medicines
The operating principle allows you to explore the design space of the process within days
instead of weeks, thereby reducing development time and cost significantly. The same machine can manufacture your development, pilot, clinical and production batches, simply by running for a longer time. This avoids lengthy and costly validation and process scale-up efforts, helping to bring your products to the market much faster.

Power your business while considering our planet
No peak consumptions, reduced space requirement, smaller buildings, smaller clean rooms. All these advantages lead to less consumption of the precious resources of our earth. With an advanced process control system resulting in guaranteed quality and avoiding the generation of toxic waste. Finally, working in a contained way to protect the operator and the environment and is prepared for production of molecules for decades to come.

NEW Innovations

Tomorrow's technology today

• Consigma™, a unique continuous granulation and drying process that drastically reduces time to market of new medicines and enables the move to a 6-Sigma process.

GEA Pharma Systems are manufacturing in India, utilizing European technology with local support.